Hospital-based monitoring of adverse drug reactions for Xiangxue Kangbingdu Oral Liquid

Phase 4, open-label, single-arm trial of Xiangxue Antiviral Oral Liquid in nasopharyngitis and influenza, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Incidence of adverse drug reaction and Incidence of serious adverse drug reaction. Started May 2012; status: completed.